BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 30982999)

  • 1. High expression of TCF12 contributes to gastric cancer development via being target regulated by miR-183 and activating PI3K/AKT pathway.
    Wang X; Gao S; Xie F; Li W; Li M; Yan N; Gao T; Fang L
    J Cell Biochem; 2019 Aug; 120(8):13903-13911. PubMed ID: 30982999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
    Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
    J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.
    Riquelme I; Tapia O; Leal P; Sandoval A; Varga MG; Letelier P; Buchegger K; Bizama C; Espinoza JA; Peek RM; Araya JC; Roa JC
    Cell Oncol (Dordr); 2016 Feb; 39(1):23-33. PubMed ID: 26458815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer.
    Zhang F; Li K; Yao X; Wang H; Li W; Wu J; Li M; Zhou R; Xu L; Zhao L
    EBioMedicine; 2019 Jun; 44():311-321. PubMed ID: 31078520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-183 affects the development of gastric cancer by regulating autophagy via MALAT1-miR-183-SIRT1 axis and PI3K/AKT/mTOR signals.
    Li H; He C; Wang X; Wang H; Nan G; Fang L
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3163-3171. PubMed ID: 31352788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.
    Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q
    J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Li YJ; Wang Y; Wang YY
    J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of microRNA-31 targeting integrin α5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells.
    Zhang XB; Song L; Wen HJ; Bai XX; Li ZJ; Ma LJ
    Tumour Biol; 2016 Jun; 37(6):8317-25. PubMed ID: 26729197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-107 regulates growth and metastasis of gastric cancer cells via activation of the PI3K-AKT signaling pathway by down-regulating FAT4.
    Wang L; Li K; Wang C; Shi X; Yang H
    Cancer Med; 2019 Sep; 8(11):5264-5273. PubMed ID: 31297980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-137 effects on gastric carcinogenesis are mediated by targeting Cox-2-activated PI3K/AKT signaling pathway.
    Cheng Y; Li Y; Liu D; Zhang R; Zhang J
    FEBS Lett; 2014 Aug; 588(17):3274-81. PubMed ID: 25064845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
    Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K
    Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-675 is frequently overexpressed in gastric cancer and enhances cell proliferation and invasion via targeting a potent anti-tumor gene PITX1.
    Liu L; Tian YC; Mao G; Zhang YG; Han L
    Cell Signal; 2019 Oct; 62():109352. PubMed ID: 31260797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway.
    Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M
    Mol Oncol; 2021 Jan; 15(1):299-316. PubMed ID: 32460412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRP4 promotes migration and invasion of gastric cancer under the regulation of microRNA-140-5p.
    Mao Z; Wang Z; Zhang S; Pu Y; Wang J; Zhang T; Long Y; Liu Y; Ma Y; Zhu J
    Cancer Biomark; 2020; 29(2):245-253. PubMed ID: 32675391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
    Cheng C; Qin Y; Zhi Q; Wang J; Qin C
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-484 suppressed proliferation, migration, invasion and induced apoptosis of gastric cancer via targeting CCL-18.
    Liu J; Li SM
    Int J Exp Pathol; 2020 Dec; 101(6):203-214. PubMed ID: 32985776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling.
    Wang H; Zhao Y; Cao L; Zhang J; Wang Y; Xu M
    J Cell Biochem; 2019 Mar; 120(3):3447-3454. PubMed ID: 30246429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-1298 expression correlates with prognosis and inhibits cell proliferation and invasion of gastric cancer.
    Qiu ZK; Liu N; Zhao SF; Ding AP; Cheng G; Qiu WS; Qi WW
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1672-1679. PubMed ID: 29630111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
    He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
    Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-937 inhibits cell proliferation and metastasis in gastric cancer cells by downregulating FOXL2.
    Yu L; Chen J; Liu Y; Zhang Z; Duan S
    Cancer Biomark; 2017 Dec; 21(1):105-116. PubMed ID: 29060929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.